Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Gemcitabine hydrochloride by Innopharmax for Metastatic Biliary Tract Cancer: Likelihood of Approval
Gemcitabine hydrochloride is under clinical development by Innopharmax and currently in Phase II for Metastatic Biliary Tract Cancer. According to...
Gemcitabine hydrochloride by Fujifilm for Non-Small Cell Lung Cancer: Likelihood of Approval
Gemcitabine hydrochloride is under clinical development by Fujifilm and currently in Phase II for Non-Small Cell Lung Cancer. According to...
Gemcitabine hydrochloride by Fujifilm for Transitional Cell Cancer (Urothelial Cell Cancer): Likelihood of Approval
Gemcitabine hydrochloride is under clinical development by Fujifilm and currently in Phase II for Transitional Cell Cancer (Urothelial Cell Cancer)....
Gemcitabine hydrochloride by Fujifilm for Solid Tumor: Likelihood of Approval
Gemcitabine hydrochloride is under clinical development by Fujifilm and currently in Phase II for Solid Tumor. According to GlobalData, Phase...
Gemcitabine hydrochloride by Fujifilm for Bile Duct Cancer (Cholangiocarcinoma): Likelihood of Approval
Gemcitabine hydrochloride is under clinical development by Fujifilm and currently in Phase I for Bile Duct Cancer (Cholangiocarcinoma). According to...
Gemcitabine hydrochloride by Fujifilm for Renal Cell Carcinoma: Likelihood of Approval
Gemcitabine hydrochloride is under clinical development by Fujifilm and currently in Phase II for Renal Cell Carcinoma. According to GlobalData,...